Results 231 to 240 of about 17,165 (261)
Some of the next articles are maybe not open access.

Administration of Albuterol by Continuous Nebulization

AACN Clinical Issues: Advanced Practice in Acute and Critical Care, 1995
Albuterol has been proven to be a vital component in the management of severe, acute asthma in children and adults. Continuous nebulization of albuterol is a relatively new administration technique for treating patients with unresponsive asthma. This method may offer the advantages of greater penetration of drug into the lung, reduced bronchospasm, and
openaire   +2 more sources

A review of the toxicology of salbutamol (albuterol)

Archives of Toxicology, 1994
This paper reviews the published toxicology of salbutamol. Salbutamol is a relatively selective beta 2-adrenoreceptor stimulant with rapid, potent bronchodilator activity and only minor inotropic or chronotropic effects. It was not found to be mutagenic. LD50 values and other acute studies indicated low toxicity.
openaire   +3 more sources

Albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane versus placebo in children with persistent asthma.

Allergy and Asthma Proceedings, 2016
BACKGROUND Many children struggle with albuterol hydrofluoroalkane (HFA) inhalers. Albuterol multidose dry powder inhaler (MDPI) may simplify rescue bronchodilator use in children.
P. Qaqundah   +3 more
semanticscholar   +1 more source

Asthma, Cardiac Arrhythmias, and Albuterol Aerosol

Chest, 1986
Twenty asthmatic patients clinically free of heart disease were studied for the possible arrhythmogenic action of albuterol (salbutamol). Two puffs of either albuterol or placebo were inhaled four times per day on two consecutive days and continuous ECG recordings obtained during each 24-hour period. Sixteen patients had atrial extrasystoles, four with
A.C. Raimondi   +2 more
openaire   +2 more sources

Clinical outcomes and treatment cost comparison of levalbuterol versus albuterol in hospitalized adults with chronic obstructive pulmonary disease or asthma.

American Journal of Health-System Pharmacy, 2015
PURPOSE Results of a prospective study comparing clinical outcomes and costs of levalbuterol versus albuterol therapy for exacerbations of asthma or chronic obstructive pulmonary disease (COPD) are presented. METHODS In a single-center open-label study,
L. Brunetti   +5 more
semanticscholar   +1 more source

Acute effect of an inhaled glucocorticosteroid on albuterol-induced bronchodilation in patients with moderately severe asthma.

Chest, 2015
BACKGROUND We have previously shown that in patients with asthma a single dose of an inhaled glucocorticosteroid (ICS) acutely potentiates inhaled albuterol-induced airway vascular smooth muscle relaxation through a nongenomic action. An effect on airway
E. Mendes   +3 more
semanticscholar   +1 more source

Pharmacokinetics and pharmacodynamics of albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane in children with asthma

Allergy and Asthma Proceedings, 2016
Many children struggle with the use of albuterol hydrofluoroalkane (HFA) inhalers. Albuterol multidose dry powder inhaler (MDPI) may simplify rescue bronchodilator use in children.To compare the pharmacokinetics (PK), pharmacodynamics (PD), and tolerability of albuterol MDPI and albuterol HFA after a single inhaled dose in children with asthma.This ...
Anoshie Ratnayake   +3 more
openaire   +3 more sources

Enhancement of Theophylline Clearance by Intravenous Albuterol

Chest, 1988
Co-administration of intravenous albuterol and theophylline resulted in increased theophylline clearance in a child with severe asthma. This required a threefold increase in theophylline dosage to maintain therapeutic serum theophylline concentrations. The possible effect of intravenous albuterol on theophylline metabolism was further supported by a 50
Simon Godfrey   +3 more
openaire   +3 more sources

Acute Myocardial Infarction Associated with Albuterol

Annals of Pharmacotherapy, 2004
OBJECTIVE To report a case of acute myocardial infarction (AMI) following the use of albuterol (salbutamol) in a patient without preexisting coronary artery disease and to review the related literature. CASE SUMMARY An 84-year-old white woman with no history of cardiac disease was treated for an exacerbation of chronic obstructive pulmonary disease ...
Alexander A. Fisher   +2 more
openaire   +3 more sources

Population pharmacokinetics of (R)-albuterol and (S)-albuterol in pediatric patients aged 4–11 years with asthma

Pulmonary Pharmacology & Therapeutics, 2007
To characterize the population pharmacokinetics (PK) of (R)- and (S)-albuterol in pediatric asthmatics using a model that supports a sparse blood sampling strategy.The data for this analysis were collected from patients enrolled in a randomized, double-blind, multicenter, placebo- and active-controlled study evaluating the safety and efficacy of ...
Thaddeus Grasela   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy